Management of pediatric brain arteriovenous malformation: a systematic review of retrospective studies

Clinical Snapshot

Key Findings

• P Value: Not applicable - no statistical testing performed

• Effect Size: Microsurgery: 81-100% obliteration (mean ~93%); SRS: 51-68.5% in largest series

• Primary Outcome: Obliteration rates varied significantly by treatment modality

• Nnt Or Sensitivity: Recurrence after apparent cure: <1% to 29% across cohorts; SRS latency-period hemorrhage: 1.1-3.2%

• Confidence Interval: Not reported - descriptive synthesis only

Clinical Application

Treatment selection heavily dependent on lesion characteristics (Spetzler-Martin grade) and institutional expertise Relevant to Australian pediatric neurosurgical centers; treatment decisions should involve multidisciplinary teams given complexity and long-term surveillance requirements Children with brain arteriovenous malformations requiring treatment decisions

Abstract

INTRODUCTION: Pediatric brain arteriovenous malformations (bAVMs) are a major cause of hemorrhagic stroke in children, yet management decisions rely largely on heterogeneous cohorts. Contemporary retrospective studies were systematically reviewed to summarize outcomes across treatment modalities and to characterize interstudy variability. METHODS: PubMed/MEDLINE was searched over the past decade for retrospective pediatric intracranial bAVM cohorts. Eligible studies reported management with observation/conservative care, endovascular embolization, microsurgical resection, stereotactic radiosurgery (SRS), or multimodality therapy. Screened studies had data extracted using a standardized form. Outcomes included obliteration, hemorrhage (first presentation and post-treatment), functional outcomes, complications, and recurrence after apparent cure. Treatment categories were harmonized into mutually exclusive groups for descriptive synthesis. RESULTS: Of 113 identified records, 20 retrospective cohort studies met the inclusion criteria. Hemorrhage was the most common presentation. Across cohorts reporting Spetzler-Martin (SM) grade, low-grade lesions (SM I-II) comprised 740 patients (44.1%), SM III 645 (38.4%), and SM IV-V 293 (17.5%). Treatment strategies varied substantially; among 1,973 classifiable patients, cohorts reported microsurgery-only, SRS-only, endovascular-only, multimodality, and conservative approaches. Definitions of obliteration and assessment methods were inconsistent (DSA-confirmed vs. MRI-based). Microsurgical series reported obliteration rates of 81%-100% in selected populations (unweighted mean ~ 93% across reporting cohorts), whereas SRS-only cohorts demonstrated obliteration rates of 51%-68.5% in the three largest unselected pediatric series (range 36%-84% across all SRS-inclusive cohorts), with latency-period hemorrhage rates of approximately 1.1%-3.2% per series. Recurrence after apparent cure was reported in 7 cohorts, with rates ranging from < 1% to 29%, occurring years after angiographic obliteration. CONCLUSIONS: Contemporary retrospective pediatric bAVM data indicate that modality-specific outcomes are strongly influenced by lesion selection, outcome definitions, and follow-up duration. Recurrence after apparent cure is not uncommon and supports explicit long-term surveillance. Standardized definitions and harmonized reporting are needed to improve interpretability and comparative inference.

References

1. 1.de Oliveira Manduca Palmiero, H., & Gadelha Figueiredo, E. (2026). Management of pediatric brain arteriovenous malformation: a systematic review of retrospective studies. Neurosurgical Review. https://doi.org/10.3171/2024.12.PEDS24211